Restricted accessResearch articleFirst published online 2026-5
Inhibition of Gemcitabine-Induced Autophagy in Cancer-Associated Fibroblasts Reduces Collagen I and Enhances Chemotherapeutic Efficacy in Pancreatic Cancer
In pancreatic cancer, increased collagen I impairs the efficacy of gemcitabine; however, the role of gemcitabine itself in collagen I accumulation remains unclear. This study aims to explore the mechanism of gemcitabine-induced fibrosis and provide new insights to enhance its therapeutic efficacy. We analyzed COL1A1 expression in pancreatic cancer patient tumor tissues and found that gemcitabine treatment upregulated COL1A1 expression. Subsequently, cancer-associated fibroblasts (CAFs) were modeled by inducing human adipose-derived mesenchymal stem cells with tumor-derived exosomes. Using the autophagy inhibitor chloroquine (CQ) and the protein kinase B (AKT) activator SC79, we demonstrated that gemcitabine downregulated P62 expression and upregulated LC3BII, Beclin-1 expression, inducing autophagy in CAFs via decreasing AKT phosphorylation, which further led to collagen I accumulation. In addition, gemcitabine combined with CQ enhanced cell death in both CAFs and tumor cells, while inhibiting tumor cell proliferation and migration. In animal models, this combination therapy reduced gemcitabine-induced autophagy and collagen I deposition, contributing to delayed tumor growth. Collectively, gemcitabine upregulates collagen I by inducing CAF autophagy via reducing AKT phosphorylation. Targeting CAF autophagy can reduce collagen deposition, offering a promising strategy to improve the therapeutic efficacy of gemcitabine in pancreatic cancer.
WangJ, YangJ, NarangA, et al.Consensus, debate, and prospective on pancreatic cancer treatments. J Hematol Oncol2024;17:92; doi: 10.1186/s13045-024-01613-x
2.
GoY-H, ChoiWH, BaeWJ, et al.Modeling pancreatic cancer with patient-derived organoids integrating cancer-associated fibroblasts. Cancers (Basel)2022;14:2077; doi: 10.3390/cancers14092077
3.
RebeloR, XavierCPR, GiovannettiE, et al.Fibroblasts in pancreatic cancer: Molecular and clinical perspectives. Trends Mol Med2023;29:439–453; doi: 10.1016/j.molmed.2023.03.002
4.
PiersmaB, HaywardMK, WeaverVM. Fibrosis and cancer: A strained relationship. Biochim Biophys Acta Rev Cancer2020;1873:188356; doi: 10.1016/j.bbcan.2020.188356
5.
LiQ, YangC, LiJ, et al.The type I collagen paradox in PDAC progression: Microenvironmental protector turned tumor accomplice. J Transl Med2025;23:744; doi: 10.1186/s12967-025-06778-8
6.
LiW, WuY, ZhangY, et al.Halofuginone disrupted collagen deposition via mTOR-eIF2α-ATF4 axis to enhance chemosensitivity in ovarian cancer. Adv Sci (Weinh)2025;12:e2416523; doi: 10.1002/advs.202416523
7.
DevosH, ZoidakisJ, RoubelakisMG, et al.Reviewing the regulators of COL1A1. Int J Mol Sci2023;24:10004; doi: 10.3390/ijms241210004
8.
QinQ, YuR, ErikssonJE, et al.Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities. Cancer Lett2024;591:216859; doi: 10.1016/j.canlet.2024.216859
9.
CaligiuriG, TuvesonDA. Activated fibroblasts in cancer: Perspectives and challenges. Cancer Cell2023;41:434–449; doi: 10.1016/j.ccell.2023.02.015
10.
Thorlacius-UssingJ, JensenC, NissenNI, et al.The collagen landscape in cancer: Profiling collagens in tumors and in circulation reveals novel markers of cancer-associated fibroblast subtypes. J Pathol2024;262:22–36; doi: 10.1002/path.6207
11.
ChittyJL, YamM, PerrymanL, Australian Pancreatic Cancer Matrix Atlas (APMA). et al.A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer. Nat Cancer2023;4:1326–1344; doi: 10.1038/s43018-023-00614-y
12.
MardhianDF, PednekarKP, HemdanAG, et al.Engineered cyclic peptide targeting ITGA5 disrupts tumor-stroma interaction to overcome desmoplasia and resistance in pancreatic ductal adenocarcinoma. Acta Pharm Sin B2026;16:305–321; doi: 10.1016/j.apsb.2025.10.022
13.
BaiJ, LiuT, TuB, et al.Autophagy loss impedes cancer-associated fibroblast activation via downregulating proline biosynthesis. Autophagy2023;19:632–643; doi: 10.1080/15548627.2022.2093026
14.
ZhangX, LaoM, YangH, et al.Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance. Autophagy2024;20:1314–1334; doi: 10.1080/15548627.2023.2300913
15.
HuangB, GaoJ, WangY, et al.ORM2 alleviates pancreatic fibrosis in chronic pancreatitis by modulating autophagy via ZG16. Pancreatology2026;26:73–82; doi: 10.1016/j.pan.2025.12.019
16.
LiuJ, WuY, MengS, et al.Selective autophagy in cancer: Mechanisms, therapeutic implications, and future perspectives. Mol Cancer2024;23:22; doi: 10.1186/s12943-024-01934-y
17.
MarchandB, PoulinMA, LawsonC, et al.Gemcitabine promotes autophagy and lysosomal function through ERK- and TFEB-dependent mechanisms. Cell Death Discov2023;9:45; doi: 10.1038/s41420-023-01342-z
18.
ZhangZ, ChenW-Q, ZhangS-Q, et al.Isoliquiritigenin inhibits pancreatic cancer progression through blockade of p38 MAPK-regulated autophagy. Phytomedicine2022;106:154406; doi: 10.1016/j.phymed.2022.154406
19.
ShenY, XueC, LiX, et al.Effects of gastric cancer cell-derived exosomes on the immune regulation of mesenchymal stem cells by the NF-kB signaling pathway. Stem Cells Dev2019;28:464–476; doi: 10.1089/scd.2018.0125
20.
YouT, TangH, WuW, et al.POSTN secretion by Extracellular Matrix Cancer-Associated Fibroblasts (eCAFs) correlates with poor ICB response via macrophage chemotaxis activation of Akt signaling pathway in gastric cancer. Aging Dis2023;14:2177–2192; doi: 10.14336/AD.2023.0503
21.
TangH, YouT, GeH, et al.Anlotinib may enhance the efficacy of anti-PD1 therapy by inhibiting the AKT pathway and promoting the apoptosis of CAFs in lung adenocarcinoma. Int Immunopharmacol2024;133:112053; doi: 10.1016/j.intimp.2024.112053
22.
GaoY, SunZ, GuJ, et al.Cancer-Associated fibroblasts promote the upregulation of PD-L1 expression through Akt phosphorylation in colorectal cancer. Front Oncol2021;11:748465; doi: 10.3389/fonc.2021.748465
23.
GommesCJ, LouisT, BourgotI, et al.Remodelling of the fibre-aggregate structure of collagen gels by cancer-associated fibroblasts: A time-resolved grey-tone image analysis based on stochastic modelling. Front Immunol2022;13:988502; doi: 10.3389/fimmu.2022.988502
24.
De MartinoD, Bravo-CorderoJJ. Collagens in cancer: Structural regulators and guardians of cancer progression. Cancer Res2023;83:1386–1392; doi: 10.1158/0008-5472.CAN-22-2034
25.
HuX, PengX, ZhangY, et al.Shikonin reverses cancer-associated fibroblast-induced gemcitabine resistance in pancreatic cancer cells by suppressing monocarboxylate transporter 4-mediated reverse Warburg effect. Phytomedicine2024;123:155214; doi: 10.1016/j.phymed.2023.155214
26.
SchuthS, Le BlancS, KriegerTG, et al.Patient-specific modeling of stroma-mediated chemoresistance of pancreatic cancer using a three-dimensional organoid-fibroblast co-culture system. J Exp Clin Cancer Res2022;41:312; doi: 10.1186/s13046-022-02519-7
27.
XiaoL, LinS, XuW, et al.Downregulation of Sox8 mediates monosodium urate crystal-induced autophagic impairment of cartilage in gout arthritis. Cell Death Discov2023;9:95; doi: 10.1038/s41420-023-01388-z
28.
YanW, XiaoGH, WangLJ, et al.CAFs activated by YAP1 upregulate cancer matrix stiffness to mediate hepatocellular carcinoma progression. J Transl Med2025;23:450; doi: 10.1186/s12967-025-06325-5
29.
LiX, ChenWW, WuJJ, et al.METTL3-dependent epigenetic regulation of ULK2 autophagy in hypertrophic scarring. Int J Biol Macromol2025;315:144507; doi: 10.1016/j.ijbiomac.2025.144507
30.
LiuC, XiaoL, CaiJ, et al.Inhibition of autophagy is involved in the collagen deposition promoted by dietary Leucin in Chu’s Croaker (Nibea coibor). J Agric Food Chem2025;73:24795–24804; doi: 10.1021/acs.jafc.5c08836
31.
ZhaoX, LiY, YuJ, et al.Role of mitochondria in pathogenesis and therapy of renal fibrosis. Metabolism2024;155:155913; doi: 10.1016/j.metabol.2024.155913
32.
HuY, LiJ, ChenH, et al.Autophagy related 5 promotes mitochondrial fission and inflammation via HSP90-HIF-1α-Mediated glycolysis in kidney fibrosis. Adv Sci (Weinh)2025;12:e2414673; doi: 10.1002/advs.202414673
33.
LiaoY, MengQ. Protection against cancer therapy-induced cardiovascular injury by planed-derived polyphenols and nanomaterials. Environ Res2023;238:116896; doi: 10.1016/j.envres.2023.116896
34.
XuJ, WangY, ShaoZ, et al.Adipose-derived stem cell exosomes attenuates myofibroblast transformation via inhibiting autophagy through TGF-β/Smad2 axis in oral submucosal fibrosis. J Nanobiotechnology2024;22:780; doi: 10.1186/s12951-024-03067-2
35.
LeeJE, LeeP, YoonY-C, et al.Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancer. Biomed Pharmacother2023;162:114716; doi: 10.1016/j.biopha.2023.114716
36.
ParkSY, JeongKJ, PoireA, et al.Nuclear cGAS mediated replication stress and mitotic catastrophe can overcome gemcitabine resistance. Cancer Lett2025;633:218009; doi: 10.1016/j.canlet.2025.218009
37.
Atlı ŞekeroğluZ, ŞekeroğluV, IşıkS, et al.Trimetazidine alone or in combination with gemcitabine and/or abraxane decreased cell viability, migration and ATP levels and induced apoptosis of human pancreatic cells. Clin Res Hepatol Gastroenterol2021;45:101632; doi: 10.1016/j.clinre.2021.101632
38.
KongL, DuJ, GuJ, et al.Gemcitabine-Loaded albumin nanoparticle exerts an antitumor effect on gemcitabine-resistant pancreatic cancer cells induced by MDR1 and MRP1 overexpression in vitro. Front Surg2022;9:890412; doi: 10.3389/fsurg.2022.890412
39.
LiuG, YangD, MengJ, et al.The combination of gemcitabine and albumin-bound paclitaxel effectively inhibits de novo lipogenesis in pancreatic cancer cells by targeting the AMPK/SREBP1 pathway. Biochem Pharmacol2025;232:116721; doi: 10.1016/j.bcp.2024.116721
40.
HuangW-C, LiuJ-C, HsiaC-W, et al.Pterostilbene, a Dimethylether analogue of resveratrol, possesses high potency in the prevention of platelet activation in humans and the reduction of vascular thrombosis in mice. J Agric Food Chem2021;69:4697–4707; doi: 10.1021/acs.jafc.1c00367
41.
DengC, LiC, DongX, et al.Atg7 senses ATP levels and regulates AKT(1)-PDCD4 phosphorylation-ubiquitination axis to promote survival during metabolic stress. Commun Biol2023;6:1252; doi: 10.1038/s42003-023-05656-7
42.
HuangY, WuG, BiG, et al.Unveiling chemotherapy-induced immune landscape remodeling and metabolic reprogramming in lung adenocarcinoma by scRNA-sequencing. Elife2024;13:RP95988; doi: 10.7554/eLife.95988
43.
LiuJ, JingW, WangT, et al.Functional metabolomics revealed the dual-activation of cAMP-AMP axis is a novel therapeutic target of pancreatic cancer. Pharmacol Res2023;187:106554; doi: 10.1016/j.phrs.2022.106554
44.
ChenY, KimJ, YangS, et al.Type I collagen deletion in αSMA(+) myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer. Cancer Cell2021;39:548–565.e6; doi: 10.1016/j.ccell.2021.02.007
45.
LeeDU, HanBS, JungKH, et al.Tumor stroma as a therapeutic target for pancreatic ductal adenocarcinoma. Biomol Ther (Seoul)2024;32:281–290; doi: 10.4062/biomolther.2024.029
46.
FanM, HuoS, GuoY, et al.UDP-glucose dehydrogenase supports autophagy-deficient PDAC growth via increasing hyaluronic acid biosynthesis. Cell Rep2024;43:113808; doi: 10.1016/j.celrep.2024.113808
47.
KarasicTB, O’HaraMH, Loaiza-BonillaA, et al.Effect of gemcitabine and nab-Paclitaxel with or without hydroxychloroquine on patients with advanced pancreatic cancer: A phase 2 randomized clinical trial. JAMA Oncol2019;5:993–998; doi: 10.1001/jamaoncol.2019.0684
48.
ZehHJ, BaharyN, BooneBA, et al.A randomized phase II preoperative study of autophagy inhibition with high-dose hydroxychloroquine and gemcitabine/nab-paclitaxel in pancreatic cancer patients. Clin Cancer Res2020;26:3126–3134; doi: 10.1158/1078-0432.CCR-19-4042
49.
LeeJJ, KearneyJF, TrembathHE, et al.Tumor-intrinsic and cancer-associated fibroblast subtypes independently predict outcomes in pancreatic cancer. Ann Surg2024;280:659–666; doi: 10.1097/SLA.0000000000006416
50.
GuY, ChenQ, YinH, et al.Cancer-associated fibroblasts in neoadjuvant setting for solid cancers. Crit Rev Oncol Hematol2024;193:104226; doi: 10.1016/j.critrevonc.2023.104226
51.
SharbeenG, McCarrollJA, AkermanA, Australian Pancreatic Cancer Genome Initiative. et al.Cancer-Associated fibroblasts in pancreatic ductal adenocarcinoma determine response to SLC7A11 inhibition. Cancer Res2021;81:3461–3479; doi: 10.1158/0008-5472.CAN-20-2496
52.
LiY-X, ZhuX-X, WuX, et al.ACLP promotes activation of cancer-associated fibroblasts and tumor metastasis via ACLP-PPARγ-ACLP feedback loop in pancreatic cancer. Cancer Lett2022;544:215802; doi: 10.1016/j.canlet.2022.215802
53.
ChenY, YangS, TavorminaJ, et al.Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer. Cancer Cell2022;40:818–834.e9; doi: 10.1016/j.ccell.2022.06.011
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
